Business Standard

Sun Pharma acquires US-based Pharmalucence

Image

Press Trust of India New Delhi
Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

Pharmalucence, which has sterile injectable capacity in the US, has been acquired by one of the subsidiaries of Sun Pharma, the Mumbai-based firm said in a statement today.

The company, however, did not disclose the financial details of the deal.

Earlier this year, Sun Pharma had acquired Ranbaxy Laboratories in an all-stock transaction with a total equity value of USD 3.2 billion along with debt of USD 800 million, taking the overall deal value to USD 4 billion.

Sun Pharma shares were trading at Rs 748.30, up 1.30 per cent from its previous close.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jul 16 2014 | 11:57 AM IST

Explore News